Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis and immunity: rewiring the tumor microenvironment for therapy. | RSC Adv | 2026 | 41726230 | PubTator, text mining | PubMed |
| Effects of curcumol on ferroptosis and tube forming ability of hepatic sinus endothelial cells. | Open Med (Wars) | 2026 | 41726127 | PubTator, text mining | PubMed |
| PDHA1 enhances resistance to ferroptosis in anoikis-resistant prostate cancer by upregulating AIFM2. | Cell Death Discov | 2026 | 41724793 | PubTator, text mining | PubMed |
| PGC-1α protects against MASH via Tim23-dependent inhibition of DRP1-mediated ferroptosis. | Cell Death Dis | 2026 | 41724762 | PubTator, text mining | PubMed |
| Identification of Pinostilbene as a natural STING agonist that triggers FTH1 degradation via K48-ubiquitination to induce ferroptosis in non-small cell lung cancer. | Redox Biol | 2026 | 41723905 | PubTator, text mining | PubMed |
| Nanomagnetic Hyperthermia Sensitizes Gemcitabine Chemosensitivity in Pancreatic Cancer by Inhibiting HSPB1 to Amplify ACSL4-Mediated Ferroptosis. | Small | 2026 | 41723828 | PubTator, text mining | PubMed |
| Targeting mitochondrial phosphatase PGAM5 alleviates ferroptosis and acute pancreatitis by upregulating NRF2-mediated FSP1 expression. | Cell Death Dis | 2026 | 41723122 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts promote osimertinib resistance in non-small cell lung cancer cells via METTL1-mediated NET1 m7G modification. | Cell Death Dis | 2026 | 41723107 | PubTator, text mining | PubMed |
| Protective Role of Physical Exercise and Exercise-Induced FNDC5/Irisin in Combating Diabetes-Related Cognitive Impairment and Autonomic and Peripheral Neuropathies: A Comprehensive Review. | J Diabetes Res | 2026 | 41716964 | PubTator, text mining | PubMed |
| Intratumoral microenvironment remodeling by lncRNA ROLLCSC enhances lung adenocarcinoma progression. | Genes Dis | 2026 | 41716631 | PubTator, text mining | PubMed |
| Shaping death: how the microbiome regulates tumour cell demise and therapy response. | Cancer Metastasis Rev | 2026 | 41714812 | PubTator, text mining | PubMed |
| Chondroitin sulfate alleviates osteoarthritis by upregulating HSPA8 to inhibit chondrocyte ferroptosis. | PLoS One | 2026 | 41712577 | PubTator, text mining | PubMed |
| ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemia. | Cell Rep | 2026 | 41712378 | PubTator, text mining | PubMed |
| Retraction: Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis. | Front Pharmacol | 2026 | 41710934 | PubTator, text mining | PubMed |
| Metabolic remodeling and immune evasion in glioblastoma: a focus on serine and lipid networks. | Front Oncol | 2026 | 41710656 | PubTator, text mining | PubMed |
| Phytochemical and Anti-Ischemic Stroke Properties from the Vitex L. Genus. | Drug Des Devel Ther | 2026 | 41710581 | PubTator, text mining | PubMed |
| Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects. | Front Endocrinol (Lausanne) | 2026 | 41710412 | PubTator, text mining | PubMed |
| Microplastic-induced multi-organ toxicity: cellular mechanisms and critical roles of organ crosstalk. | Front Public Health | 2026 | 41710308 | PubTator, text mining | PubMed |
| SREBP1-activated lipid metabolism drives ferroptosis and progression of clear cell renal cell carcinoma. | Sci China Life Sci | 2026 | 41706270 | PubTator, text mining | PubMed |
| Non-canonical cell death in neurodegeneration: emerging mechanisms and therapeutic Frontiers. | Apoptosis | 2026 | 41699331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=20